ARPC5 and cholangiocarcinoma: In our analyses, we found that the most frequent mutation type of ARPC5 was “Amplification” mutation and the frequency of “Amplification” was varied among different cancer types, which was most commonly observed in cholangiocarcinoma, invasive breast carcinoma, and HCC.